why choose us

First received: September 22, 2022

Clinical Trial: eVusheld Assessment reaL wORld Effectiveness in the VA Health System

Study Status: Completed

Recruit Status: RECRUITING

Condition: SARS-CoV-2, COVID-19

Study Type: OBSERVATIONAL


Official Title: An Observational Study to Assess the Real-World Effectiveness of EVUSHELD™ (Tixagevimab/Cilgavimab) as Pre-exposure Prophylaxis Against COVID-19 Among EVUSHELD-eligible Populations Receiving Care

Brief Summary: An AstraZeneca-sponsored observational, electronic healthcare record (EHR)-embedded retrospective cohort study to assess the real-world effectiveness of EVUSHELD against SARS-CoV-2 infection, COVID-19-related hospitalization, and other COVID-19 related outcomes in the total EUA-eligible patient population in the Department of Veterans Affairs (VA) Health System.

Read more